Ran Frenkel - Insider Trading & Ownership

Location
C/O Karyopharm Therapeutics Inc., 85 Wells Avenue, 2 Nd Floor, Newton, MA
Summary
The estimated net worth of Ran Frenkel is at least $138K dollars as of March 2, 2022. Ran Frenkel is the EVP, Chief Dev. Officer of Karyopharm Therapeutics Inc. and owns shares of Karyopharm Therapeutics Inc. (KPTI) stock worth about $138K.
Signature
/s/ Nancy Smith as Attorney-in-Fact for Ran Frenkel
All Insider Reports
All Insider Reports

Ownership of Ran Frenkel

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KPTI Karyopharm Therapeutics Inc. EVP, Chief Dev. Officer $138K Feb 28, 2022

Insider Transactions Reported by Ran Frenkel:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.